Skip to main content


Effects of DA-5513 on alcohol metabolism and alcoholic fatty liver in rats


Hangover is characterized by a number of unpleasant physical and mental symptoms that occur after heavy alcohol drinking. In addition, consistently excessive alcohol intake is considered as a major reason causes liver disease. The present study investigated the in vivo effects of DA-5513 (Morning careê Kang Hwang) on biological parameters relevant to hangover relief and alcoholic fatty liver. Blood alcohol and acetaldehyde concentrations were determined in rats administered a single dose of alcohol and treated with DA-5513 or commercially available hangover relief beverages (Yeomyungê and Ukonê). The effects of DA-5513 on alcoholic fatty liver were also determined in rats fed alcohol-containing Lieber-DeCarli diets for 4 weeks. Serum liver function markers (aspartate and alanine aminotransferase activities) and serum/liver lipid levels were assessed. Blood alcohol and acetaldehyde concentrations were lower in the groups treated with DA-5513 or Yeomyungê, as compared with control rats. However, Ukonê did not produce any significant effects on these parameters. Treatment with DA-5513 significantly reduced serum aspartate and alanine aminotransferase activities and markedly reduced serum cholesterol and triglyceride levels, as compared with control rats. Histological observations using Oil Red O staining found that DA-5513 delayed the development of alcoholic fatty liver by reversing hepatic fat accumulation. These findings suggest that DA-5513 could have a beneficial effect on alcohol-induced hangovers and has the potential to ameliorate alcoholic fatty liver.


  1. 1.

    Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y, Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet 2009; 373(9682): 2223–2233.

  2. 2.

    Wiese J, McPherson S, Odden MC, Shlipak MG. Effect of Opuntia ficus indica on symptoms of the alcohol hangover. Arch Intern Med 2004; 164(12): 1334–1340.

  3. 3.

    Swift R, Davidson D. Alcohol hangover: mechanisms and mediators. Alcohol Health Res World 1998; 22(1): 54–60.

  4. 4.

    Lieber CS. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 2004; 34(1): 9–19.

  5. 5.

    Altamirano J, Bataller R. Alcoholic liver disease: pathogenesis and new targets for therapy. Nat Rev Gastroenterol Hepatol 2011; 8(9): 491–501.

  6. 6.

    Purohit V, Gao B, Song BJ. Molecular mechanisms of alcoholic fatty liver. Alcohol Clin Exp Res 2009; 33(2): 191–205.

  7. 7.

    Lafontan M, Girard J. Impact of visceral adipose tissue on liver metabolism: Part I: Heterogeneity of adipose tissue and functional properties of visceral adipose tissue. Diabetes Metab 2008; 34(4): 317–327.

  8. 8.

    Wree A, Kahraman A, Gerken G, Canbay A. Obesity affects the liver-the link between adipocytes and hepatocytes. Digestion 2011; 83(1-2): 124–133.

  9. 9.

    Zhong W, Zhao Y, Tang Y, Wei X, Shi X, Sun W, Sun X, Yin X, Sun X, Kim S, McClain CJ, Zhang X, Zhou Z. Chronic alcohol exposure stimulates adipose tissue lipolysis in mice: role of reverse triglyceride transport in the pathogenesis of alcoholic steatosis. Am J Pathol 2012; 180(3): 998–1007.

  10. 10.

    Addolorato G, Capristo E, Greco AV, Stefanini GF, Gasbarrini G. Influence of chronic alcohol abuse on body weight and energy metabolism: is excess ethanol consumption a risk factor for obesity or malnutrition? J Intern Med 1998; 244(5): 387–395.

  11. 11.

    Li Y, Wong K, Giles A, Jiang J, Lee JW, Adams AC, Kharitonenkov A, Yang Q, Gao B, Guarente L, Zang M. Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21. Gastroenterology 2014; 146(2): 539–549. e7.

  12. 12.

    Suter PM, Schutz Y, Jequier E. The effect of ethanol on fat storage in healthy subjects. N Engl J Med 1992; 326(15): 983–987.

  13. 13.

    Neuschwander-Tetri BA. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology 2010; 52(2): 774–788.

  14. 14.

    Pulido-Moran M, Moreno-Fernandez J, Ramirez-Tortosa C, Ramirez-Tortosa M. Curcumin and health. Molecules 2016; 21(3): 264.

  15. 15.

    You Y, Duan X, Wei X, Su X, Zhao M, Sun J, Ruenroengklin N, Jiang Y. Identification of major phenolic compounds of Chinese water chestnut and their antioxidant activity. Molecules 2007; 12(4): 842–852.

  16. 16.

    Vargas-Mendoza N, Madrigal-Santillán E, Morales-González Á, Esquivel-Soto J, Esquivel-Chirino C, García-Luna y González-Rubio M, Gayosso-de-Lucio JA, Morales-González JA. Hepatoprotective effect of silymarin. World J Hepatol 2014; 6(3): 144–149.

  17. 17.

    Chang BY, Lee DS, Lee JK, Kim YC, Cho HK, Kim SY. Protective activity of kudzu (Pueraria thunbergiana) vine on chemically-induced hepatotoxicity: in vitro and in vivo studies. BMC Complement Altern Med 2016; 16: 39.

  18. 18.

    Mattei R, Dias RF, Espínola EB, Carlini EA, Barros SB. Guarana (Paullinia cupana): toxic behavioral effects in laboratory animals and antioxidants activity in vitro. J Ethnopharmacol 1998; 60(2): 111–116.

  19. 19.

    Cheng N, Du B, Wang Y, Gao H, Cao W, Zheng J, Feng F. Antioxidant properties of jujube honey and its protective effects against chronic alcohol-induced liver damage in mice. Food Funct 2014; 5(5): 900–908.

  20. 20.

    Kober H, Tatsch E, Torbitz VD, Cargnin LP, Sangoi MB, Bochi G V, da Silva AR, Barbisan F, Ribeiro EE, da Cruz IB, Moresco RN. Genoprotective and hepatoprotective effects of Guarana (Paullinia cupana Mart. var. sorbilis) on CCl4-induced liver damage in rats. Drug Chem Toxicol 2016; 39(1): 48–52.

  21. 21.

    Kim CI, Leo MA, Lowe N, Lieber CS. Differential effects of retinoids and chronic ethanol consumption on membranes in rats. J Nutr 1988; 118(9): 1097–1103.

  22. 22.

    Yin HQ, Lee BH. Temporal changes in the hepatic fatty liver in mice receiving standard Lieber-DeCarli diet. Toxicological Research 2008; 24(2): 113–117.

  23. 23.

    Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Canadian journal of biochemistry and physiology 1959; 37(8): 911–917.

  24. 24.

    Levene AP, Kudo H, Thursz MR, Anstee QM, Goldin RD. Is oil red-O staining and digital image analysis the gold standard for quantifying steatosis in the liver? Hepatology 2010; 51(5): 1859.

  25. 25.

    Kucherenko MM, Marrone AK, Rishko VM, Yatsenko AS, Klepzig A, Shcherbata HR. Paraffin-embedded and frozen sections of drosophila adult muscles. J Vis Exp 2010; (46): 2438.

  26. 26.

    Fakhoury-Sayegh N, Trak-Smayra V, Khazzaka A, Esseily F, Obeid O, Lahoud-Zouein M, Younes H. Characteristics of nonalcoholic fatty liver disease induced in wistar rats following four different diets. Nutr Res Pract 2015; 9(4): 350–357.

  27. 27.

    Yogalakshmi B, Sreeja S, Geetha R, Radika MK, Anuradha C V. Grape Seed Proanthocyanidin Rescues Rats from Steatosis: A Comparative and Combination Study with Metformin. J Lipids 2013; 2013: 153897.

  28. 28.

    Lieber CS. Alcohol: its metabolism and interaction with nutrients. Annual review of nutrition 2000; 20(1): 395–430.

  29. 29.

    Lu Y, Cederbaum AI. CYP2E1 and oxidative liver injury by alcohol. Free Radic Biol Med 2008; 44(5): 723–738.

  30. 30.

    Guengerich FP, Beaune PH, Umbenhauer DR, Churchill PF, Bork RW, Dannan GA, Knodell R G, Lloyd RS, Martin M V. Cytochrome P-450 enzymes involved in genetic polymorphism of drug oxidation in humans. Biochem Soc Trans 1987; 15(4): 576–578.

  31. 31.

    Stewart S, Jones D, Day CP. Alcoholic liver disease: new insights into mechanisms and preventative strategies. Trends Mol Med 2001; 7(9): 408–413.

  32. 32.

    Ceni E, Mello T, Galli A. Pathogenesis of alcoholic liver disease: role of oxidative metabolism. World J Gastroenterol 2014; 20(47): 17756–17772.

  33. 33.

    Lakshman MR. Some novel insights into the pathogenesis of alcoholic steatosis. Alcohol 2004; 34(1): 45–48.

  34. 34.

    Lieber CS, DeCarli LM, Sorrell MF. Experimental methods of ethanol administration. Hepatology 1989; 10(4): 501–510.

  35. 35.

    Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, Angulo P. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005; 129(1): 113–121.

  36. 36.

    Hong M, Li S, Tan H Y, Wang N, Tsao SW, Feng Y. Current status of herbal medicines in chronic liver disease therapy: the biological effects, molecular targets and future prospects. Int J Mol Sci 2015; 16(12): 28705–28745.

  37. 37.

    Lee HS, Song J, Kim TM, Joo SS, Park D, Jeon JH, Shin S, Park HK, Lee WK, Ly S Y, Kim MR, Lee DI, Kim YB. Effects of a preparation of combined glutathione-enriched yeast and rice embryo/soybean extracts on ethanol hangover. J Med Food 2009; 12(6): 1359–1367.

  38. 38.

    Takahashi H, Greenway H, Matsumura H, Tsutsumi N, Nakazono M. Rice alcohol dehydrogenase 1 promotes survival and has a major impact on carbohydrate metabolism in the embryo and endosperm when seeds are germinated in partially oxygenated water. Ann Bot 2014; 113(5): 851–859.

  39. 39.

    Kiso Y, Suzuki Y, Watanabe N, Oshima Y, Hikino H. Antihepatotoxic principles of Curcuma longa rhizomes. Planta medica 1983; 49(11): 185–187.

  40. 40.

    Reddy AC, Lokesh BR. Effect of dietary turmeric (Curcuma longa) on iron-induced lipid peroxidation in the rat liver. Food Chem Toxicol 1994; 32(3): 279–283.

  41. 41.

    Sasaki H, Sunagawa Y, Takahashi K, Imaizumi A, Fukuda H, Hashimoto T, Wada H, Katanasaka Y, Kakeya H, Fujita M, Hasegawa K, Morimoto T. Innovative preparation of curcumin for improved oral bioavailability. Biol Pharm Bull 2011; 34(5): 660–665.

  42. 42.

    Hamano T, Nishi M, Itoh T, Ebihara S, Watanabe Y. The effect of beverage containing curcuma longa L. extract on the alcohol metabolism of healthy volunteers. Oyo Yakuri (Pharmacometrics) 2007; 72(1-2): 31–38.

  43. 43.

    Kamal-Eldin A, Frank J, Razdan A, Tengblad S, Basu S, Vessby B. Effects of dietary phenolic compounds on tocopherol, cholesterol, and fatty acids in rats. Lipids 2000; 35(4): 427–435.

  44. 44.

    Fehér J, Deák G, Müzes G, Láng I, Niederland V, Nékám K, Kárteszi M. Liver-protective action of silymarin therapy in chronic alcoholic liver diseases. Orv Hetil 1989; 130(51): 2723–2727.

  45. 45.

    Ferenci P, Dragosics B, Dittrich H, Frank H, Benda L, Lochs H, Meryn S, Base W, Schneider B. Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. J Hepatol 1989; 9(1): 105–113.

  46. 46.

    Kim YS, Hwang JW, Jang JH, Son S, Seo IB, Jeong JH, Kim EH, Moon SH, Jeon BT, Park PJ. Trapa japonica pericarp extract reduces LPS-induced inflammation in macrophages and acute lung injury in mice. Molecules 2016; 21(3): 392.

  47. 47.

    Kim YS, Hwang JW, Han YK, Kwon HJ, Hong H, Kim EH, Moon SH, Jeon BT, Park PJ. Antioxidant activity and protective effects of Trapa japonica pericarp extracts against tert-butylhydroperoxide-induced oxidative damage in Chang cells. Food Chem Toxicol 2014; 64: 49–56.

  48. 48.

    Kim YS, Kim EK, Hwang JW, Seo IB, Jang JH, Son S, Jeong JH, Moon SH, Jeon BT, Park PJ. Characterization of the antioxidant fraction of Trapa japonica pericarp and its hepatic protective effects in vitro and in vivo. Food Funct 2016; 7(3): 1689–1699.

  49. 49.

    Chen G, Li L. Nutrient consumption and production of isoflavones in bioreactor cultures of Pueraria Iobata (Willd). J Environ Biol 2007; 28(2): 321–326.

  50. 50.

    Yamazaki T, Hosono T, Matsushita Y, Kawashima K, Someya M, Nakajima Y, Narui K, Hibi Y, Ishizaki M, Kinjo J, Nohara T. Pharmacological studies on Puerariae Flos. IV: Effects of Pueraria thomsonii dried flower extracts on blood ethanol and acetaldehyde levels in humans. Int J Clin Pharmacol Res 2002; 22(1): 23–28.

  51. 51.

    Shi P, Chen B, Chen C, Xu J, Shen Z, Miao X, Yao H. Honey reduces blood alcohol concentration but not affects the level of serum MDA and GSH-Px activity in intoxicated male mice models. BMC Complement Altern Med 2015; 15: 225.

  52. 52.

    Lowenstein LM, Simone R, Boulter P, Nathan P. Effect of fructose on alcohol concentrations in the blood in man. JAMA 1970; 213(11): 1899–1901.

Download references

Author information

Correspondence to Jong Oh Kim.

Rights and permissions

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Yu, J.Y., Nguyen, H.T., Yong, C.S. et al. Effects of DA-5513 on alcohol metabolism and alcoholic fatty liver in rats. Lab Anim Res 34, 49–57 (2018).

Download citation


  • Morning careê
  • hangover
  • acetaldehyde
  • alcohol-induced fatty liver
  • hepatic triglyceride